Agenus and Dr. Steven O’Day Participate in B. Riley SITC 2020 Immuno-Oncology Virtual Panel
November 12, 2020 at 1:00 PM EST
Panel #2: Next-Gen Checkpoint Inhibitors (CPI) and Co-Stimulatory Agonists Finally Ready for Prime Time
Speakers:
- Steven O’Day, MD – Executive Directo of the John Wayne Cancer Institute
- Jennifer Buell, PhD – President and COO of Agenus
- Patrick Jordan – COO of AgenTus Therapeutics
Panel #3: Cell Therapy 2.0: Transforming Immune Cells to Mainstream Cancer Treatments
Speakers:
- Jennifer Buell, PhD – President & COO of Agenus
- Patrick Jordan – COO of AgenTus Therapeutics